Loading…
Loading…
I was wondering if share buybacks are potentially on the table
the current state of what you're seeing in terms of demand for life science leasing and supply across your markets
Can you give us an update on 360 Park Avenue leasing. Doug, you mentioned you got it leased on the last night
Biogen announced some layoffs to their research department last week, and they are your third largest tenant
How are you viewing the industry today? And what's your appetite to invest more into that category through any of your investment vehicles
Could you talk through your ATM strategy today given the improved cost of capital?
maybe you could update us on your watch list today. And could you update us on your Red Lobster exposure given they're back in the headlines
It increased by $0.04, but it didn't really help the -- increase the full year AFFO guidance
Does that include the fund investments? Just trying to get an understanding of how we should break down the investment guidance
your dispositions on your -- in your vacant assets increased sequentially
if this could potentially change your strategy as it relates to Europe versus U.S. investments
are you seeing any market dislocations across larger portfolio transactions that you could potentially take advantage of
you mentioned that they were all released and were able to capture 94% of your prior ABR
curious what needs to happen for you to achieve the high end of your guidance there
you saw the cap rates compress by thirty basis points. Just curious what drove the compression there